Swiss pharma Acino partners with UAE’s Pharmax to boost regional operations

The Swiss healthcare giant focuses on gastroenterology, pain relief, and the cardiovascular system in its UAE portfolio. (Supplied)

• The agreement covers the licensing, manufacturing, and supply of Acino products across the Middle East and Africa
• It is in line with UAE’s aim to be a regional pharmaceutical manufacturing hub

DUBAI: Swiss pharmaceutical company Acino signed a partnership with UAE-based Pharmax to boost its operations in the region.
The agreement covers the licensing, manufacturing, and supply of Acino products across the Middle East and Africa, the pair said in a statement.
It is in line with UAE’s aim to be a regional pharmaceutical manufacturing hub, health ministry official Amin Hussen Al-Amiri said, “especially in the production of innovative and similar medicines in local factories in the UAE,” he added.
The country will benefit from Acino’s reputation of acquiring international high-quality brands, Al-Amiri said.
“Acino is committed to advancing the development of healthcare across the UAE and the wider region by accelerating access to high-quality medicines that patients and governments can trust and value,” the company’s regional general manager Anrew Bird said.
The Swiss healthcare giant focuses on gastroenterology, pain relief, and the cardiovascular system in its UAE portfolio.